These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32354675)

  • 1. Impact of Alzheimer's disease and related dementia diagnosis following treatment for bladder cancer.
    Jazzar U; Shan Y; Klaassen Z; Freedland SJ; Kamat AM; Raji MA; Masel T; Tyler DS; Baillargeon J; Kuo YF; Mehta HB; Bergerot CD; Williams SB
    J Geriatr Oncol; 2020 Sep; 11(7):1118-1124. PubMed ID: 32354675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
    Williams SB; Shan Y; Jazzar U; Mehta HB; Baillargeon JG; Huo J; Senagore AJ; Orihuela E; Tyler DS; Swanson TA; Kamat AM
    JAMA Surg; 2018 Oct; 153(10):881-889. PubMed ID: 29955780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of psychiatric illness on decreased survival in elderly patients with bladder cancer in the United States.
    Jazzar U; Yong S; Klaassen Z; Huo J; Hughes BD; Esparza E; Mehta HB; Kim SP; Tyler DS; Freedland SJ; Kamat AM; Wolf DV; Williams SB
    Cancer; 2018 Aug; 124(15):3127-3135. PubMed ID: 29660813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent muscle-invasive bladder cancer after neoadjuvant chemotherapy: an analysis of Surveillance, Epidemiology and End Results-Medicare data.
    Lane G; Risk M; Fan Y; Krishna S; Konety B
    BJU Int; 2019 May; 123(5):818-825. PubMed ID: 30126053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: a SEER database analysis.
    Canter D; Egleston B; Wong YN; Smaldone MC; Simhan J; Greenberg RE; Uzzo RG; Kutikov A
    Urol Oncol; 2013 Aug; 31(6):866-70. PubMed ID: 21906968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dementia, Alzheimer's Disease, and Mortality after Hemodialysis Initiation.
    McAdams-DeMarco MA; Daubresse M; Bae S; Gross AL; Carlson MC; Segev DL
    Clin J Am Soc Nephrol; 2018 Sep; 13(9):1339-1347. PubMed ID: 30093374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of orthotopic neobladder vs ileal conduit urinary diversion after cystectomy on the survival outcomes in patients with bladder cancer: A propensity score matched analysis.
    Su X; Wu K; Wang S; Su W; Li C; Li B; Mao X
    Cancer Med; 2020 Oct; 9(20):7590-7600. PubMed ID: 32869540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delays in radical cystectomy for muscle-invasive bladder cancer.
    Chu AT; Holt SK; Wright JL; Ramos JD; Grivas P; Yu EY; Gore JL
    Cancer; 2019 Jun; 125(12):2011-2017. PubMed ID: 30840335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire.
    Chahal R; Sundaram SK; Iddenden R; Forman DF; Weston PM; Harrison SC
    Eur Urol; 2003 Mar; 43(3):246-57. PubMed ID: 12600427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital length of stay following radical cystectomy for muscle-invasive bladder cancer: Development and validation of a population-based prediction model.
    Ray-Zack MD; Shan Y; Mehta HB; Yu X; Kamat AM; Williams SB
    Urol Oncol; 2019 Nov; 37(11):837-843. PubMed ID: 30446462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based assessment of racial/ethnic differences in utilization of radical cystectomy for patients diagnosed with bladder cancer.
    Williams SB; Huo J; Kosarek CD; Chamie K; Rogers SO; Williams MA; Giordano SH; Kim SP; Kamat AM
    Cancer Causes Control; 2017 Jul; 28(7):755-766. PubMed ID: 28477210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health Related Quality of Life Following Radical Cystectomy: Comparative Analysis from the Medicare Health Outcomes Survey.
    Winters BR; Wright JL; Holt SK; Dash A; Gore JL; Schade GR
    J Urol; 2018 Mar; 199(3):669-675. PubMed ID: 28882404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of adjuvant chemotherapy in radical cystectomy patients aged >65 years: a population-based study from the surveillance epidemiology and end results (SEER)-medicare database.
    Schiffmann J; Sun M; Gandaglia G; Tian Z; Popa I; Larcher A; Briganti A; McCORMACK M; Shariat SF; Montorsi F; Graefen M; Saad F; Karakiewicz PI
    Minerva Urol Nefrol; 2017 Apr; 69(2):173-180. PubMed ID: 27733752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Effectiveness of Treatment Strategies for Squamous Cell Carcinoma of the Bladder.
    Stensland KD; Zaid H; Broadwin M; Sorcini A; Canes D; Galsky M; Moinzadeh A
    Eur Urol Oncol; 2020 Aug; 3(4):509-514. PubMed ID: 31411987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do African American Patients Treated with Radical Cystectomy for Bladder Cancer have Worse Overall Survival? Accounting for Pathologic Staging and Patient Demographics Beyond Race Makes a Difference.
    Kaye DR; Canner JK; Kates M; Schoenberg MP; Bivalacqua TJ
    Bladder Cancer; 2016 Apr; 2(2):225-234. PubMed ID: 27376141
    [No Abstract]   [Full Text] [Related]  

  • 16. Disparities in Bladder Cancer Treatment and Survival Amongst Elderly Patients with a Pre-existing Mental Illness.
    Sathianathen NJ; Fan Y; Jarosek SL; Konety I; Weight CJ; Vinogradov S; Konety BR
    Eur Urol Focus; 2020 Nov; 6(6):1180-1187. PubMed ID: 30797737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population.
    Schrag D; Mitra N; Xu F; Rabbani F; Bach PB; Herr H; Begg CB
    Urology; 2005 Jun; 65(6):1118-25. PubMed ID: 15922428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program.
    Konety BR; Joslyn SA
    J Urol; 2003 Nov; 170(5):1765-71. PubMed ID: 14532772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities.
    Richards KA; Ham S; Cohn JA; Steinberg GD
    Int J Urol; 2016 Jan; 23(1):42-7. PubMed ID: 26443388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and survival in patients with recurrent high-risk non-muscle-invasive bladder cancer.
    Chamie K; Ballon-Landa E; Daskivich TJ; Bassett JC; Lai J; Hanley JM; Konety BR; Litwin MS; Saigal CS;
    Urol Oncol; 2015 Jan; 33(1):20.e9-20.e17. PubMed ID: 25443267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.